The approval time for FDA registration and certification in the United States varies depending on the type of product and the specific regulatory process involved. Here’s a detailed overview:

1. Medical Devices:

   • 510(k) Notification: The FDA typically reviews 510(k) submissions within 90 days. However, this period can extend if the FDA requests additional information or if there are issues with the submission. Overall, from initial preparation to final approval, the process may take around 3 to 6 months.
   • Premarket Approval (PMA): The review period for PMA applications usually ranges from 180 to 360 days. This process is more complex and involves thorough evaluation of clinical and non-clinical data. Including preparation time and potential follow-ups, obtaining PMA certification might take up to a year or more.
   • De Novo Classification: The review time for De Novo requests is generally about 120 days. This process is used for novel devices not previously classified and may take longer if additional data or clarification is required.

2. Drugs:

   • New Drug Application (NDA): The FDA’s standard review time for NDAs is approximately 10 months. If the drug qualifies for priority review, this period can be reduced to around 6 months. The total time from submission to approval, including potential interactions with the FDA, can range from 6 to 12 months.
   • Abbreviated New Drug Application (ANDA): The review process for generic drugs typically takes around 10 months. This timeline may vary based on submission completeness and any additional information requests from the FDA.

3. Biologics:

   • Biologics License Application (BLA): The standard review period for BLAs is about 10 months. For priority review, this can be shortened to approximately 6 months. The overall time required, including preparation and communication with the FDA, might be around 6 to 12 months.

4. Food Products:

   • Generally Recognized as Safe (GRAS) Notification: The review time for GRAS notifications can vary widely, often taking several months to a year, depending on the complexity and completeness of the safety data provided.

Overall, while these timelines provide a general framework, actual approval times can be influenced by factors such as the completeness of the submission, the need for additional information, and the FDA’s workload.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn